TI - Cytokine-targeted therapy in severely ill COVID-19 patients: Options and cautions PT - Journal Article DP - 2020 TA - EJMO PG - 179-181 VI - 4 IP - 2 AID - 2020.72142 [doi] 4100 - https://dx.doi.org/10.14744/ejmo.2020.72142 SO - EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY,2020 4(2): 179